Earnings Alerts

New China Life Insurance (601336) Earnings Surge: 9-Month Net Income Climbs 95% to 115%

  • New China Life Insurance is projecting a significant increase in net income for the first nine months of 2024.
  • The preliminary net income is expected to rise between 95% and 115%.
  • The estimated net income range is between 18.6 billion yuan to 20.5 billion yuan.
  • Analyst recommendations for the stock include 13 buys, 8 holds, and 2 sells.

A look at New China Life Insurance Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience2
Momentum5
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Investors looking at New China Life Insurance may find a promising long-term outlook based on the Smartkarma Smart Scores assessment. With a strong momentum score of 5, the company seems to be showing robust performance trends that could bode well for its future growth. Additionally, the high scores in both value and dividend categories, rated at 4 each, indicate that the company is competitively priced and offers attractive dividend returns, which could be appealing to value investors seeking stable income.

However, it’s worth noting that New China Life Insurance‘s resilience score of 2 and growth score of 3 suggest some areas of caution. The lower resilience score may indicate potential vulnerability to economic downturns or industry challenges, while the growth score could imply a slower pace of expansion compared to its peers. Overall, investors may want to consider these factors alongside the positive momentum, value, and dividend attributes when evaluating the company for long-term investment potential.

Summary: New China Life Insurance Company Limited offers a variety of life, accident, and health insurance products and services. This company provides insurance in both local and foreign currencies, acts as an insurance agent, and offers insurance consulting services.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars